| First Author | Silha JV | Year | 2002 |
| Journal | Endocrinology | Volume | 143 |
| Issue | 10 | Pages | 3711-4 |
| PubMed ID | 12239079 | Mgi Jnum | J:79472 |
| Mgi Id | MGI:2388261 | Doi | 10.1210/en.2002-220116 |
| Citation | Silha JV, et al. (2002) Insights from insulin-like growth factor binding protein transgenic mice. Endocrinology 143(10):3711-4 |
| abstractText | The existence of abundant high affinity binding proteins for the IGFs, the IGF binding proteins (IGFBPs), was first demonstrated more than 40 yr ago in the very early days of somatomedin research. With the development of molecular techniques and transgenic and knockout mouse models, the nature, complexity, and redundancy of the IGFBPs have now started to be elucidated. Indeed the functional role of the circulating IGFs and the originally proposed endocrine somatomedin hypothesis have recently been questioned. The limited reports to date indicate that IGFBP knockout mice have few phenotypic manifestations. In contrast, overexpression of IGFBPs in transgenic mice is associated with manifestations that provide some insight into the physiological role of the binding proteins. The predominant effect of generalized or tissue-specific overexpression of the IGFBPs has been growth inhibition as would be anticipated from inhibition of the actions of IGF-I and -II. In addition, impaired glucose homeostasis and reduced fecundity have been observed in both IGFBP-1- and IGFBP-3-overexpressing transgenic mice. This review examines the data reported to date for transgenic mouse models that overexpress IGFBPs. In addition, data from transgenic mice that overexpress the acid-labile subunit, an important component of the ternary complex, have also been reviewed. |
